Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview
Conference Call Scheduled for March 31, 2025 4:30pm ET VANCOUVER, British Columbia & DALLAS, March 19, 2025–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that […]
